Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 21;13(4):e14611.
doi: 10.7759/cureus.14611.

Dementia and Adherence to Anti-Diabetic Medications: A Meta-Analysis

Hyder Mirghani  1 , Samar Aljohani  2 , Afaf Albalawi  1
Affiliations

Dementia and Adherence to Anti-Diabetic Medications: A Meta-Analysis

Hyder Mirghani et al. Cureus. .

Abstract

Introduction Diabetes mellitus (DM) and dementia (DN) are common morbid disorders with high mortality, the two disorders shared the pathogenesis of proinflammation and insulin resistance. Polypharmacy is expected when DM and DN co-exist and medication adherence is essential to an effective self-care and management plan. This meta-analysis aimed to assess medication persistence among patients with diabetes and cognitive impairment (CogImp). Methods We systematically searched the literature through PubMed, Medline, Cochrane library, and the first 100 articles published in Google Scholar. We included articles publishes in English and conducted on humans, no limitation was set to the date of publication, all the articles were approached from the first published up to March 15, 2021. The keywords used were Dementia, cognitive impairment, cognitive decline, cognitive dysfunction, diabetes self-care, compliance to anti-diabetic drugs, and medication adherence. One hundred-seventy-six were identified, the 12 full texts screened, only four fulfilled the inclusion and exclusion criteria. Results The studies were published in Europe, the United States, and Asia (all were observational). The results showed no effects of dementia on medication adherence, P-value of 0.41, odd ratio: 1.09, 95% CI: 0.89-1.32, Chi-square for heterogeneity: 12.15, I2 = 75%, and standard difference = 3. The P-value for heterogeneity was 0.007. The studies included 2,556 patients and 1,854 events. Conclusion No association was found between dementia and compliance to anti-diabetic medications. Further prospective studies are needed to solve the issue.

Keywords: dementia; diabetes mellitus; medications adherence.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. The different phases of the systematic review regarding the association of dementia and adherence to anti-diabetic drugs (the PRISMA chart).
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 2
Figure 2. The relationship of dementia and adherence to anti-diabetic medications.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Williams R, Karuranga S, Malanda B, et al. Diabetes Res Clin Pract. 2020;162:108072. - PubMed
    1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Saeedi P, Petersohn I, Salpea P, et al. Diabetes Res Clin Pract. 2019;157:107843. - PubMed
    1. Approximating dementia prevalence in population-based surveys of aging worldwide: An unsupervised machine learning approach. Cleret de Langavant L, Bayen E, Bachoud-Lévi AC, Yaffe K. Alzheimers Dement. 2020;6:0. - PMC - PubMed
    1. Association between body mass index and prevalence of multimorbidity in low- and middle-income countries: a cross-sectional study. Agrawal S, Agrawal PK. Int J Med Public Health. 2016;6:73–78. - PMC - PubMed
    1. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Lancet Diabetes Endocrinol. 2020;8:535–545. - PubMed

LinkOut - more resources